David S. Wichmann net worth and biography

David Wichmann Biography and Net Worth

SHARE
    
Jump to Section Nav
David Wichmann was named chief executive officer of UnitedHealth Group in September 2017.  He also served as president since November 2014, chief financial officer of the enterprise from 2011 until mid-2016 and has overseen UnitedHealthcare since 2014.  He previously held positions as president, UnitedHealthcare; president and chief executive officer, Specialized Care Services (now OptumHealth); and senior vice president, Corporate Development.  Prior to joining UnitedHealth Group in 1998, Wichmann was a partner with Arthur Andersen.  He is the board chair of the YMCA of the Greater Twin Cities and a board member of Tennant Company.

What is David S. Wichmann's net worth?

The estimated net worth of David S. Wichmann is at least $8.83 million as of December 3rd, 2020. Mr. Wichmann owns 16,472 shares of UnitedHealth Group stock worth more than $8,831,628 as of December 2nd. This net worth approximation does not reflect any other assets that Mr. Wichmann may own. Learn More about David S. Wichmann's net worth.

What is David S. Wichmann's salary?

As the CEO of UnitedHealth Group Incorporated, Mr. Wichmann earned a total compensation package of $11,221,093.00 in 2021. Mr. Wichmann earned a salary of $393,077.00, and other compensation of $10,828,016.00. Learn More on David S. Wichmann's salary.

How do I contact David S. Wichmann?

The corporate mailing address for Mr. Wichmann and other UnitedHealth Group executives is 9900 BREN ROAD EAST, MINNETONKA MN, 55343. UnitedHealth Group can also be reached via phone at (952) 936-1300 and via email at [email protected] Learn More on David S. Wichmann's contact information.

Has David S. Wichmann been buying or selling shares of UnitedHealth Group?

David S. Wichmann has not been actively trading shares of UnitedHealth Group within the last three months. Most recently, on Friday, May 3rd, David S. Wichmann bought 20,000 shares of UnitedHealth Group stock. The stock was acquired at an average cost of $231.79 per share, with a total value of $4,635,800.00. Following the completion of the transaction, the chief executive officer now directly owns 904,367 shares of the company's stock, valued at $209,623,226.93. Learn More on David S. Wichmann's trading history.

Who are UnitedHealth Group's active insiders?

UnitedHealth Group's insider roster includes Richard Burke (Director), Paul Garcia (Director), Stephen Hemsley (Director), Patricia Lewis (EVP), Dirk McMahon (Pres & COO ), Dirk McMahon (CEO), Frederick McNabb, III (Director), Erin Mcsweeney (EVP), Steven Nelson (CEO), Larry Renfro (Insider), John Rex (CFO), Thomas Roos (CAO), Marianne Short (EVP), Brian Thompson (Exec. VP & CEO of UnitedHealthcare), David Wichmann (CEO), D. Wilson (EVP), and Andrew Witty (CEO). Learn More on UnitedHealth Group's active insiders.

Are insiders buying or selling shares of UnitedHealth Group?

During the last twelve months, UnitedHealth Group insiders bought shares 2 times. They purchased a total of 2,235 shares worth more than $1,042,710.10. During the last twelve months, insiders at the healthcare conglomerate sold shares 13 times. They sold a total of 168,324 shares worth more than $88,640,600.48. The most recent insider tranaction occured on August, 26th when CAO Thomas E Roos sold 465 shares worth more than $252,202.05. Insiders at UnitedHealth Group own 0.4 % of the company. Learn More about insider trades at UnitedHealth Group.

Information on this page was last updated on 8/26/2022.

David S. Wichmann Insider Trading History at UnitedHealth Group

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/3/2019Buy20,000$231.79$4,635,800.00904,367View SEC Filing Icon  
See Full Table

David S. Wichmann Buying and Selling Activity at UnitedHealth Group

This chart shows David S Wichmann's buying and selling at UnitedHealth Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

UnitedHealth Group Company Overview

UnitedHealth Group logo
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
Read More

Today's Range

Now: $536.16
Low: $532.44
High: $538.61

50 Day Range

MA: $525.90
Low: $498.86
High: $555.15

2 Week Range

Now: $536.16
Low: $445.17
High: $558.10

Volume

2,330,199 shs

Average Volume

3,145,019 shs

Market Capitalization

$500.96 billion

P/E Ratio

26.26

Dividend Yield

1.23%

Beta

0.73